Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wolenski FS"'
Autor:
Mosedale M; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: merrie@unc.edu., Cai Y; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: ywcai@email.unc.edu., Eaddy JS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, United States. Electronic address: jseaddy@gmail.com., Kirby PJ; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: patrick.kirby@dragonflytx.com., Wolenski FS; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: fwolenski@gmail.com., Dragan Y; Takeda Pharmaceuticals International Co., Cambridge, MA, 02139, United States. Electronic address: yvonne.dragan@takeda.com., Valdar W; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States. Electronic address: william.valdar@unc.edu.
Publikováno v:
Toxicology [Toxicology] 2021 Sep; Vol. 461, pp. 152902. Date of Electronic Publication: 2021 Aug 18.
Autor:
Longo DM; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Woodhead JL; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Walker P; Cyprotex, Inc., Macclesfield SK10 4TG, UK., Herédi-Szabó K; SOLVO Biotechnology, Szeged 6728, Hungary., Mogyorósi K; SOLVO Biotechnology, Szeged 6728, Hungary., Wolenski FS; Takeda Pharmaceuticals International, Inc., Cambridge, Massachusetts 02139., Dragan YP; Takeda Pharmaceuticals International, Inc., Cambridge, Massachusetts 02139., Mosedale M; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Siler SQ; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709., Watkins PB; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina 27709., Howell BA; DILIsym Services, Inc., Research Triangle Park, North Carolina 27709.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2019 Feb 01; Vol. 167 (2), pp. 458-467.
Autor:
Wolenski FS; Drug Safety Research and Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Xia CQ; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Ma B; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Han TH; Seattle Genetics Inc., Bothell, WA, USA., Shyu WC; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA., Balani SK; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., 35 Landsdowne Street, Cambridge, MA, USA. suresh.balani@takeda.com.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2018 Jun; Vol. 43 (3), pp. 347-354.
Autor:
Wolenski FS; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Zhu AZX; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Johnson M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Yu S; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Moriya Y; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan., Ebihara T; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan., Csizmadia V; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Grieves J; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Paton M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Liao M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Gemski C; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Pan L; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA., Vakilynejad M; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA., Dragan YP; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Chowdhury SK; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA., Kirby PJ; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2017 May 01; Vol. 157 (1), pp. 50-61.
Autor:
Wolenski FS; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Shah P; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Sano T; Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan., Shinozawa T; Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan., Bernard H; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Gallacher MJ; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Wyllie SD; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Varrone G; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Cicia LA; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Carsillo ME; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Fisher CD; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Ottinger SE; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Koenig E; Molecular Pathology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA., Kirby PJ; Drug Safety Research & Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, 02139, USA.
Publikováno v:
Journal of applied toxicology : JAT [J Appl Toxicol] 2017 Mar; Vol. 37 (3), pp. 278-286. Date of Electronic Publication: 2016 Jul 11.
Autor:
Csizmadia V; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Hales P; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Tsu C; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Ma J; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Chen J; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Shah P; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Fleming P; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Senn JJ; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Kadambi VJ; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Dick L; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620., Wolenski FS; Millennium Pharmaceuticals , Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited) , Cambridge , MA 02139 , USA . Email: Vilmos.Csizmadia@Takeda.com ; ; Tel: +1 617-551-3620.
Publikováno v:
Toxicology research [Toxicol Res (Camb)] 2016 Aug 25; Vol. 5 (6), pp. 1619-1628. Date of Electronic Publication: 2016 Aug 25 (Print Publication: 2016).
Autor:
Koenig EM; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA. Erik.Koenig@Takeda.com., Fisher C; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Bernard H; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Wolenski FS; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Gerrein J; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Carsillo M; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Gallacher M; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Tse A; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Peters R; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Smith A; Eli Lilly and Company, 893 S. Delaware, Indianapolis, IN, 46285, USA., Meehan A; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Tirrell S; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Kirby P; Takeda Pharmaceuticals International Co., 40 Landsdowne Street, Cambridge, MA, 02139, USA.
Publikováno v:
BMC genomics [BMC Genomics] 2016 Aug 17; Vol. 17, pp. 649. Date of Electronic Publication: 2016 Aug 17.
Autor:
Wolenski FS; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), 35 Landsdowne Street, Cambridge, MA 02139, USA., Dragan YP; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), 35 Landsdowne Street, Cambridge, MA 02139, USA.
Publikováno v:
Cell death & disease [Cell Death Dis] 2015 Nov 19; Vol. 6, pp. e1988. Date of Electronic Publication: 2015 Nov 19.
Autor:
Wolenski FS; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Fisher CD; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Sano T; Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa , Kanagawa, Japan., Wyllie SD; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Cicia LA; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Gallacher MJ; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Baker RA; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Kirby PJ; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA., Senn JJ; Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
Publikováno v:
Cell death discovery [Cell Death Discov] 2015 Oct 05; Vol. 1, pp. 15034. Date of Electronic Publication: 2015 Oct 05 (Print Publication: 2015).
Autor:
Layden MJ; The Whitney Marine Laboratory for Marine Science, University of Florida, St. Augustine, Florida, USA., Röttinger E, Wolenski FS, Gilmore TD, Martindale MQ
Publikováno v:
Nature protocols [Nat Protoc] 2013 May; Vol. 8 (5), pp. 924-34. Date of Electronic Publication: 2013 Apr 11.